全球骶神经刺激市场研究报告-行业分析、规模、份额、增长、趋势及2023年至2030年预测

骶神经刺激市场的全球需求预计将从2022年的22.8亿美元增长到2030年的69.4亿美元，2023-2030年的复合年增长率为14.9%。

骶神经刺激或骶神经调控是一种医疗程序，涉及使用电刺激来调节骶神经的活动。这些神经位于骶骨，负责控制膀胱、肠道和盆底肌肉。该疗法主要用于治疗保守疗法无效的某些膀胱和肠道功能障碍。

市场动态：

膀胱和肠道功能障碍，如膀胱过度活动症（OAB）、尿潴留和大便失禁，是影响很大一部分人口的普遍问题。这些疾病的发病率不断上升，因此更需要有效的治疗方案，包括骶神经刺激术。该疗法为对保守疗法无反应或不能耐受保守疗法的患者提供了另一种选择。全球人口老龄化导致膀胱和肠道功能障碍的发病率上升，从而引发了对骶神经刺激术等有效干预措施的需求。体积更小、性能更先进的植入式神经刺激器的开发以及编程能力的增强扩大了市场潜力。该手术在缓解症状、改善膀胱/肠道控制和提高患者生活质量方面取得了积极成果。随着这些优点越来越为人所知并得到临床证据的支持，患者和医疗服务提供者越来越多地将骶神经刺激作为一种治疗选择。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构，评估全球范围内的竞争吸引力。此外，这些工具还对全球骶神经刺激市场的各个细分市场进行了全面评估。骶神经刺激器行业的增长和趋势为本研究提供了整体方法。

市场细分：

骶神经刺激器市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按产品分类

• 植入式
• 外用

按应用

• 大小便失禁
• 急迫性尿失禁
• 慢性肛裂
• 其他

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太、拉美、中东和非洲骶神经刺激市场的当前和未来需求。此外，报告还重点介绍了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。骶神经刺激市场的主要参与者包括Medtronic PLC、Axonics Modulation Technologies, Inc.、Nuvectra和Cogentix Medical。本节对竞争格局进行了整体分析，包括各种战略发展，如关键并购、未来产能、合作伙伴关系、财务概况、合作、新产品开发、新产品上市及其他发展。

目 录

第一章：前言

• 报告描述
  • 报告目标
  • 目标受众
  • 独特销售主张（USP）和产品
• 研究范围
• 研究方法
  • 市场调研流程
  • 市场调研方法

第二章：执行摘要

• 市场亮点
• 全球市场概况

第三章：骶神经刺激-行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制因素
• 市场机会
• 行业趋势
• 波特五力分析
• 市场吸引力分析
  • 按产品分类的市场吸引力分析
  • 市场吸引力分析：按应用
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原材料制造商列表
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直接营销
  • 间接营销
  • 营销渠道发展趋势

第五章：全球骶神经刺激器市场分析：按产品分类

• 产品概述
• 历史和预测数据
• 按产品分析
• 植入式
• 外置式

第六章：全球骶神经刺激市场分析：按应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 大小便失禁
• 急迫性尿失禁
• 慢性肛裂
• 其他

第七章 ：全球骶神经刺激市场分析：按地理区域划分

• 地区展望
• 产品介绍
• 北美销售分析
  • 概述、历史和预测数据 销售分析
  • 北美地区销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测数据 销售分析
  • 欧洲销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测数据 销售分析
  • 亚太地区细分市场销售分析
  • 亚太地区各国销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 亚太其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测数据 销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测数据 销售分析
  • 中东及非洲地区销售分析
  • 中东及非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东及非洲其他地区销售分析

第八章 : 骶神经刺激器企业竞争格局

• 骶神经刺激器市场竞争格局
• 伙伴关系/合作/协议
• 合并与收购
• 新产品发布
• 其他发展

第九章 : 公司简介

• 顶级公司市场份额分析
• 市场集中度
• Medtronic PLC
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Axonics Modulation Technologies Inc.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Nuvectra
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Cogentix Medical
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展

注-在公司概况中，财务细节和近期发展视情况而定，如果是私营公司则可能不包括在内。

The global demand for Sacral Nerve Stimulation Market is presumed to reach the market size of nearly USD 6.94 BN by 2030 from USD 2.28 BN in 2022 with a CAGR of 14.9% under the study period 2023 - 2030.

Sacral nerve stimulation, or sacral neuromodulation, is a medical procedure that involves the use of electrical stimulation to modulate the activity of the sacral nerves. These nerves are located in the sacrum and are responsible for controlling the bladder, bowel, and pelvic floor muscles. This procedure is primarily used to treat certain bladder and bowel dysfunctions that have not responded to conservative treatments.

Market Dynamics:

Bladder and bowel dysfunctions, such as overactive bladder (OAB), urinary retention, and faecal incontinence, are prevalent issues affecting a significant portion of the population. The rising incidence of these conditions creates a greater need for effective treatment options, including sacral nerve stimulation. This process offers an alternative for individuals who have not responded to or cannot tolerate conservative therapies. The global population is ageing, leading to an increased prevalence of bladder and bowel dysfunctions, thereby leading to the demand for effective interventions such as sacral nerve stimulation. The development of smaller, more advanced implantable neurostimulators and enhanced programming capabilities have expanded the market potential. This procedure has demonstrated positive outcomes in terms of symptom relief, improved bladder/bowel control, and enhanced quality of life for patients. As these benefits become more well-known and supported by clinical evidence, both patients and healthcare providers are increasingly seeking sacral nerve stimulation as a treatment option.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of sacral nerve stimulation. The growth and trends of sacral nerve stimulation industry provide a holistic approach to this study.

Market Segmentation:

This section of the sacral nerve stimulation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Implantable
• External

By Application

• Urinary & Fecal Incontinence
• Urge Incontinence
• Chronic Anal Fissure
• Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Sacral Nerve Stimulation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the sacral nerve stimulation market include Medtronic PLC; Axonics Modulation Technologies, Inc.; Nuvectra; Cogentix Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . SACRAL NERVE STIMULATION - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SACRAL NERVE STIMULATION MARKET ANALYSIS BY PRODUCT

• 5.1 Overview by Product
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product
• 5.4 Implantable Historic and Forecast Sales by Regions
• 5.5 External Historic and Forecast Sales by Regions

6 . GLOBAL SACRAL NERVE STIMULATION MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Urinary & Fecal Incontinence Historic and Forecast Sales by Regions
• 6.5 Urge Incontinence Historic and Forecast Sales by Regions
• 6.6 Chronic Anal Fissure Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL SACRAL NERVE STIMULATION MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE SACRAL NERVE STIMULATION COMPANIES

• 8.1. Sacral Nerve Stimulation Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF SACRAL NERVE STIMULATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Medtronic PLC
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Axonics Modulation Technologies Inc.
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Nuvectra
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Cogentix Medical
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Implantable Market Sales by Geography (USD MN)
• External Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Urinary & Fecal Incontinence Market Sales by Geography (USD MN)
• Urge Incontinence Market Sales by Geography (USD MN)
• Chronic Anal Fissure Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Sacral Nerve Stimulation Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Sacral Nerve Stimulation Report
• Market Research Process
• Market Research Methodology
• Global Sacral Nerve Stimulation Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Implantable Market Sales by Geography (USD MN)
• External Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Urinary & Fecal Incontinence Market Sales by Geography (USD MN)
• Urge Incontinence Market Sales by Geography (USD MN)
• Chronic Anal Fissure Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.